J&J Bows Out of Race for Pfizer's $20B Consumer Health Biz Post author:Sam Post published:January 25, 2018 Post category:BioPharma Now insiders say J&J has decided it is no longer interested. Source: BioSpace You Might Also Like SurModics Announces 2017 Annual Shareholders Meeting February 8, 2017 9 Massachusetts Biotechs Facing Major FDA Decisions This Year March 2, 2017 Strike It Rich With These 3 Biotech Stocks That Have Late-Stage Drugs April 10, 2017
